Poor responses to tyrosine kinase inhibitors in a child with precursor B‐cell acute lymphoblastic leukemia with SNX2‐ABL1 chimeric transcript
Authors:
- 28 November 2013
- journal article
- case report
- Published by Wiley in European Journal of Haematology
- Vol. 92 (3) , 263-267
Abstract
In addition to BCR, various rare fusion partners for the ABL1 gene have been reported in leukemia. We have identified the fusion gene SNX2-ABL1 in a pediatric case of acute lymphoblastic leukemia (ALL), which has only once previously been reported in an adult patient. Cytogenetic analysis detected this fusion gene arising from a t(5;9)(q22;q34) translocation. ALL cells carrying a SNX2-ABL1 fusion exhibited a BCR-ABL1+ ALL-like gene expression profile. The patient poorly responded to dasatinib but partially responded to imatinib. Treatment using tyrosine kinase inhibitors requires further investigation to optimize the genotype-based treatment stratification for patients with SNX2-ABL1 fusion.Keywords
This publication has 19 references indexed in Scilit:
- Episomal amplification of NUP214-ABL1 fusion gene in B-cell acute lymphoblastic leukemiaBlood, 2012
- Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic LeukemiaCancer Cell, 2012
- ABL1 fusion genes in hematological malignancies: a reviewEuropean Journal of Haematology, 2011
- Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemiaBritish Journal of Haematology, 2011
- Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: Poor prognosis and prenatal originGenes, Chromosomes and Cancer, 2010
- A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34)Haematologica, 2009
- Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemiaLeukemia, 2008
- Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocationLeukemia, 2007
- Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemiaNature Reviews Cancer, 2007
- Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemiaNature Genetics, 2004